USP5 and neoplasm: As tumor angiogenesis plays an important role in chemotherapy resistance and anti-angiogenic agents were usually combined with chemotherapeutics in the clinic,47 we thus assessed whether inhibiting USP5 may enhance the antitumor efficacy of chemotherapy in ESCC (Fig. 6d).